Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
about
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesStatins in heart failure: do we need another trial?Gene polymorphisms in association with emerging cardiovascular risk markers in adult womenGout and the risk for incident heart failure and systolic dysfunction.Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.Hyperuricemia and incident heart failure.Serum Uric Acid level in the severity of Congestive Heart Failure (CHF).Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data.Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failureRelationship between CCR and NT-proBNP in Chinese HF patients, and their correlations with severity of HF.Serum uric acid as a cardiovascular risk factor for heart disease.Serum uric acid is not an independent risk factor for coronary heart disease.Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathyThe independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study.The management of hyperuricemia and gout in patients with heart failure.Contemporary epidemiology of gout in the UK general populationSerum uric acid and cardiovascular disease.Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndromeEffect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU studyEffects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.Laboratory and echocardiography markers in sickle cell patients with leg ulcersGout, not induced by diuretics? A case-control study from primary care.Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.Coronary artery bypass grafting in a patient with gout arthritis.High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo.Hyperuricemia: An Early Marker for Severity of Illness in Sepsis.The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure.Serum uric acid as an index of impaired renal function in congestive heart failure.Role of xanthine oxidoreductase in cardiac nitroso-redox imbalanceEffects of aerobic exercise training on psychosocial status and serum uric Acid in men with essential hypertension: a randomized controlled trial.Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy.Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.Should a statin be prescribed to every patient with heart failure?Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?Uric acid administration in patients with acute stroke: a novel approach to neuroprotection.Xanthine oxidoreductase in respiratory and cardiovascular disorders.Serum uric acid: a forgotten prognostic marker in acute coronary syndromes?Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes).
P2860
Q26784322-5293E1EC-ECD0-4225-BD75-7B8CE25072CAQ26998966-2710DE2E-4C43-46FA-A47D-B8DF38DCADAAQ28393721-5C6A392E-50C9-4E3E-B5E6-647CEEBBA6B0Q30505423-AF1117BC-AF89-4855-B27A-DC6757C3E0C3Q31129762-E0BC9C9E-5AC2-4146-83EE-5F2CBC78A3A5Q33572047-C14620E1-0414-491D-B7B9-149FD83548F2Q33690310-DB17EDB2-F506-4FC7-8EB6-89140E306EF2Q33784030-05C146F3-5502-4A19-BE88-496ABBD0452CQ34102097-BB8C2EEA-15AD-447A-BA6C-4A8DA540239FQ34183461-530A32A3-2192-4BF3-9B36-E2DAB242410BQ34251312-8E67FE00-A9A6-4675-8648-A91C5903231CQ34251321-53EC98F4-7895-4E9C-8080-DD1D7126767DQ34450910-99089E96-10F4-4A1D-8015-A79E51B2F02DQ34481181-CD39EF3F-89CD-452A-9A40-D90AB68D910CQ34495600-D87FC715-728A-46D3-AB98-CD31F05FA0A6Q34776806-9378C61A-8B83-4E63-8BF6-56BC0794BCEBQ35092887-ACB2268E-C529-4EE0-922A-08D6F3FB06F9Q35225010-42FE21FE-125F-4712-B67B-B57F4873C931Q35376033-C1928D4D-9D1E-471F-97AE-A6041D9BE4F8Q35561264-67CCDFF9-F3F9-4A8E-8F45-9ECBE5748A76Q35627898-8BA366B0-0C56-4A2A-9D77-4A45A2C22319Q35632843-E9DD8386-577A-433D-9BD9-2ACDC158D17CQ35637489-13250941-AD95-4490-8DC5-5BD213A5FFACQ35685117-03B75F62-1737-48A3-98CC-7111B4CCD33DQ35733468-E1DC6BC7-73C4-467D-BEF9-44D1D6413EFAQ35912071-71889B9D-0CF8-4017-98F3-344D6CFA95CDQ35941771-8B6B8F4A-B9B4-4AFE-B57C-FD5D6C63EDD7Q36142224-FA718E71-1D6D-404B-8C5A-D564F64B19DEQ36163701-42503A2A-03FF-4750-8566-44BF5F48D1C5Q36557850-3B86F0B0-7E12-4030-A1B1-6521EAD12DEAQ36612882-BFDA7A0B-1729-4DCE-833C-36E67457920CQ36769535-1BACCC5B-FB57-4367-A06E-2C16102DE2C9Q36846087-C208CD01-CD0C-4496-9BD2-120B0E2A91C5Q36908540-E2DBE49E-1D4A-4557-880E-984862B7DD39Q37018125-3861378A-9B27-40E0-84F6-A1A4381F029DQ37078795-3610E614-71DD-4956-8BAB-7A330D936470Q37083643-04A37BF6-7284-401A-ABA3-644898F37BF0Q37111434-1CC1EB8D-921C-4088-A180-E844AA36D36AQ37141009-77BAE002-557C-4B57-B0C2-171C89F8EDCBQ37322413-542FA5A7-87FE-4D0D-BCCA-A7833956CA3B
P2860
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@en
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@nl
type
label
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@en
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@nl
prefLabel
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@en
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@nl
P2093
P1476
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
@en
P2093
C S Wingrove
I F Godsland
J C Stevenson
P304
P356
10.1093/OXFORDJOURNALS.EURHEARTJ.A015352
P577
1997-05-01T00:00:00Z